Advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression.
VIEW PRODUCT PIPELINEAbout
We are a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders..
Read MoreLatest News
Xenon Outlines Key Corporate Milestone Opportunities for 2025
Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
View All News >
Investors
Visit our Investor page for News Releases, Annual & Quarterly Reports, Webcasts & Events
View Investor Area
